Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S N Avdeev

Showing results (11-20 of 65) with videos related to

Pageof 7
Sort By:
Terapevticheskii Arkhiv|June 30, 2020
[Risk stratification methods and their significance in pulmonary arterial hypertension]S N Avdeev, N A Tsareva
Terapevticheskii Arkhiv|October 18, 2017
[A patient with severe idiopathic pulmonary arterial hypertension: Is there a way out?]N A Tsareva, S N Avdeev, G V Neklyudova
Problemy Sotsial'Noi Gigieny, Zdravookhraneniia I Istorii Meditsiny|November 14, 2025
[The estimated expenditures on medicinal support of patients with chronic obstructive disease of lungs]S A Linnik, E E Tumenko, S N Avdeev
Terapevticheskii Arkhiv|February 1, 2019
Combination therapy is a new standard for treatment of pulmonary arterial hypertensionS N Avdeev, N A TsarEva, I R Gaisin
Terapevticheskii Arkhiv|June 30, 2020
[Systemic inflammation in patients with chronic obstructive pulmonary disease and obesity]E S Ovsyannikov, S N Avdeev, A V Budnevsky
Antibiotiki I Khimioterapiia = Antibiotics and Chemoterapy [Sic]|January 1, 1997
[Effectiveness of ciprofloxacin in the treatment of hospital infections of the lower respiratory tract]A G Chuchalin, Iu K Novikov, S N Avdeev, et al.
Terapevticheskii Arkhiv|April 25, 2000
[Effectiveness of antiinflammatory therapy in patients with interstitial lung diseases using re-assay of biomarker mucin 3EG5]O E Avdeeva, Iu S Lebedin, S N Avdeev, et al.
Terapevticheskii Arkhiv|December 28, 2024
[The effectiveness of vaccination against pneumococcal infection in patients with severe bronchial asthma]G L Ignatova, S N Avdeev, V N Antonov, et al.
Terapevticheskii Arkhiv|May 6, 2025
[Chronic bronchitis - new clinical recommendations (main provisions): A review on behalf of the working group for the development and revision of clinical guidelines for chronic bronchitis]I V Leshchenko, S N Avdeev, A A Zaytsev, et al.
Terapevticheskii Arkhiv|May 31, 2013
[First clinical experience with endothelin receptor antagonist bosentan used in patients with pulmonary hypertension: results of a one-year study]S N Avdeev, N A tsareva, G V Nekliudova, et al.
Pageof 7

Showing results (11-20 of 65) with videos related to

Sort By:
Pageof 7
Terapevticheskii Arkhiv|June 30, 2020
[Risk stratification methods and their significance in pulmonary arterial hypertension]S N Avdeev, N A Tsareva
Terapevticheskii Arkhiv|October 18, 2017
[A patient with severe idiopathic pulmonary arterial hypertension: Is there a way out?]N A Tsareva, S N Avdeev, G V Neklyudova
Problemy Sotsial'Noi Gigieny, Zdravookhraneniia I Istorii Meditsiny|November 14, 2025
[The estimated expenditures on medicinal support of patients with chronic obstructive disease of lungs]S A Linnik, E E Tumenko, S N Avdeev
Terapevticheskii Arkhiv|February 1, 2019
Combination therapy is a new standard for treatment of pulmonary arterial hypertensionS N Avdeev, N A TsarEva, I R Gaisin
Terapevticheskii Arkhiv|June 30, 2020
[Systemic inflammation in patients with chronic obstructive pulmonary disease and obesity]E S Ovsyannikov, S N Avdeev, A V Budnevsky
Antibiotiki I Khimioterapiia = Antibiotics and Chemoterapy [Sic]|January 1, 1997
[Effectiveness of ciprofloxacin in the treatment of hospital infections of the lower respiratory tract]A G Chuchalin, Iu K Novikov, S N Avdeev, et al.
Terapevticheskii Arkhiv|April 25, 2000
[Effectiveness of antiinflammatory therapy in patients with interstitial lung diseases using re-assay of biomarker mucin 3EG5]O E Avdeeva, Iu S Lebedin, S N Avdeev, et al.
Terapevticheskii Arkhiv|December 28, 2024
[The effectiveness of vaccination against pneumococcal infection in patients with severe bronchial asthma]G L Ignatova, S N Avdeev, V N Antonov, et al.
Terapevticheskii Arkhiv|May 6, 2025
[Chronic bronchitis - new clinical recommendations (main provisions): A review on behalf of the working group for the development and revision of clinical guidelines for chronic bronchitis]I V Leshchenko, S N Avdeev, A A Zaytsev, et al.
Terapevticheskii Arkhiv|May 31, 2013
[First clinical experience with endothelin receptor antagonist bosentan used in patients with pulmonary hypertension: results of a one-year study]S N Avdeev, N A tsareva, G V Nekliudova, et al.
Pageof 7